United States · 
Who invested in Visus Therapeutics?
Visus Therapeutics's investors include RTW Investments LLC and EQT Life Sciences.
United States · Funded startup
Who invested in Visus Therapeutics
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2021, from 1 source
- Latest round
- Debt, $20MAug 2021
- Investors
- 2
The rounds
- Aug 2021
Founders and team
From Visus Therapeutics's own website: 14 on the team.
- Henric BjarkeChief Executive Officer
- Brandi RobinsonVice President of Corporate Affairs
- Esther CunoVice President of
- Lindari Nol-MorinVice President of Compliance
- Yemisi CorinaldiVice President of Regulatory Affairs
- Carol KearneyChief Commercial Officer
- Melissa EpperlyChief Financial Officer
- Tim GrinsteadChief Operating Officer
- Alexander PasteurDirector
- Carmine CircelliDirector
- Graziano SeghezziDirector
- Jim MazzoDirector
- Tracy M. ValorieDirector
- Ben BergoTeam
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Visus Therapeutics
How much has Visus Therapeutics raised?
Visus Therapeutics has raised $20M across 1 round since 2021.
When did Visus Therapeutics last raise?
Visus Therapeutics's most recent round was a Debt of $20M in Aug 2021.
What was Visus Therapeutics's biggest round?
Its most recent round, $20M in Aug 2021, is also its largest on record.
Who backed Visus Therapeutics first?
Visus Therapeutics's first round on record, in Aug 2021, was backed by RTW Investments LLC and EQT Life Sciences.
What stage is Visus Therapeutics at?
Visus Therapeutics's latest named round is a Debt, in Aug 2021.
Where is Visus Therapeutics based?
Visus Therapeutics is based in the United States.
Companies like Visus Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.